Identification of EGR4 as a Prospective Target for Inhibiting Tumor Cell Proliferation and a Novel Biomarker in Colorectal Cancer

The authors assessed the prognosis of colorectal cancer (CRC) based on early growth response 4 (EGR4) using the Kaplan-Meier plotter tool and tissue microarray.